Opakalim is currently in development for the treatment of focal onset seizures. Credit: Berit Kessler / Shutterstock.com. The US Food and Drug Administration (FDA) has placed a partial clinical hold ...
The study is evaluating the efficacy and safety of arlo-cel in patients who have previously received CAR T-cell therapies. Credit: PanuShot / Shutterstock.com. Bristol Myers Squibb (BMS) has reported ...
For efficacy, 26 participants were evaluable across both dose groups. Credit: Sai Thaw Kyar / Shutterstock.com. Tyra Biosciences has reported initial data from its Phase II SURF302 clinical trial of ...
The trial enrolled 248 adults aged 18 to 70 with moderate-to-severe SLE. Credit: Jarun Ontakrai / Shutterstock.com. Beeline Medicines has announced that its global Phase II clinical trial involving ...
Novartis will now assess the next steps for del-desiran’s development programme. Credit: 24K-Production / Shutterstock.com. Novartis’ Avidity Biosciences-acquired therapy, delpacibart etedesiran ...
OBERON and TITANIA were double-blind, placebo-controlled Phase III trials enrolling just over 2,300 patients with a history of two or more moderate or one or more severe COPD exacerbations in the ...
Recruitment was supported by the NIHR Clinical Research Facility at King’s. Credit: King’s College Hospital NHS Foundation Trust. The UK’s King’s College Hospital NHS Foundation Trust has announced ...
Wilson disease is caused by ATP7B gene mutations. Credit: Saiful52 / Shutterstock.com. Orphalan has launched the TRADITiONAL Study, a global Phase III clinical trial of an investigational once-daily ...
There are currently limited pharmaceutical treatment options for patients with obesity under 12 years of age. Credit: New Africa / Shutterstock.com. Novo Nordisk’s blockbuster weight loss drug, Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results